ArticleJournal of fungi (Basel, Switzerland)2023
Special Issue: Fungal Nanotechnology 2.
Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal nanotechnology provides techniques useful for molecular and cell biology, medicine, biotechnology, agriculture, veterinary physiology, and reproduction. This technology also has exciting potential applications in pathogen identification and treatment, as well as impressive outcomes in the animal and food systems. Myconanotechnology is a viable option for the synthesis of green nanoparticles because it is simple, affordable, and more environmentally friendly to use fungal resources. Mycosynthesis nanoparticles can be used for various purposes, such as pathogen detection and diagnosis, control, wound healing, drug delivery, cosmetics, food preservation, and textile fabrics, among other applications. They can be applied to a variety of industries, such as agriculture, manufacturing, and medicine. Gaining deeper comprehension of the molecular biology and genetic components underlying the fungal nanobiosynthetic processes is becoming increasingly important. This Special Issue aims to showcase recent advancements in invasive fungal diseases caused by human, animal, plant, and entomopathogenic fungi that are being identified, treated, and treated using antifungal nanotherapy. Utilizing fungus in nanotechnology has several benefits, such as their capacity to create nanoparticles with distinctive characteristics. As an illustration, some fungi can create nanoparticles that are highly stable, biocompatible, and have antibacterial capabilities. Fungal nanoparticles may be used in a variety of industries, including biomedicine, environmental cleanup, and food preservation. Fungal nanotechnology is also a sustainable and environmentally beneficial method. Fungi are an appealing alternative to conventional chemical methods of creating nanoparticles because they are simple to cultivate using affordable substrates and may be cultivated under diverse conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.